Joe and Mike Minogue, the recent CEO of Abiomed which was sold to Johnson & Johnson for $16 billion discuss some of the principles and the mindset of how to build high performing teams and enable success.

Joe and Mike Minogue, the recent CEO of Abiomed which was sold to Johnson & Johnson for $16 billion discuss some of the principles and the mindset of how to build high performing teams and enable success.

Joe and Mike Minogue, the recent CEO of Abiomed which was sold to Johnson &amp; Johnson for $16 billion discuss some of the principles and the mindset of how to build high performing teams and enable success.&nbsp;

Mike Minogue on Leadership and Abiomed

The Untitled Podcast is designed to get you to think. Not what to think, but think. We cover subjects in healthtech, medtech, personal performance, and leadership.

Business

Careers

The Untitled Podcast is designed to get you to think. Not what to think, but think. We cover subjects in healthtech, medtech, personal performance, and leadership.

Share Mike Minogue on Leadership and Abiomed

Sign up to save your podcasts

Mike Minogue on Leadership and Abiomed

Mike Minogue on Leadership and Abiomed